The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer.

Leal, Ana S; Liu, Phillip; Krieger-Burke, Teresa; Ruggeri, Bruce; Liby, Karen T

Leal, Ana S; Liu, Phillip; Krieger-Burke, Teresa; Ruggeri, Bruce; Liby, Karen T.

Afiliação

Leal AS; Department of Pharmacology & Toxicology, Michigan State University, B430 Life Science Building, 1355 Bogue Street, East Lansing, MI 48824, USA.
Liu P; Incyte Corporation, Wilmington, DE 19803, USA.
Krieger-Burke T; Department of Pharmacology & Toxicology, Michigan State University, B430 Life Science Building, 1355 Bogue Street, East Lansing, MI 48824, USA.
Ruggeri B; Incyte Corporation, Wilmington, DE 19803, USA.
Liby KT; Department of Pharmacology & Toxicology, Michigan State University, B430 Life Science Building, 1355 Bogue Street, East Lansing, MI 48824, USA.

Cancers (Basel) ; 13(1)2020 Dec 30.

Article em En | MEDLINE | ID: mdl-33396954

Palavras-chave

bromodomain inhibitors; inflammatory tumor microenvironment; pancreatic cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google